As mentioned above, patients treated with Unity® experienced lower rates of xerostomia and dysgeusia one and three months post-RT compared with those treated with Radixact®, although those benefits did not reach statistical significance.
← all excerpts
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy.
1
—
—